Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Johann

Gudjonsson

,

MD, PhD

Professor of Dermatology
Professor of Internal Medicine, Division of Rheumatology
Director, University of Michigan Skin Research Center
University of Michigan, Department of Dermatology
Ann Arbor
,
Michigan
,
United States
Councilor Since: January 1, 2014
IPC Board Member
Request an Update
Dr. Johann Gudjonsson is the Arthur C. Curtis Professor of Skin Molecular Immunology and Professor of Dermatology, Internal Medicine Division of Rheumatology, and a Taubman Medical Research Institute Scholar at the University of Michigan. Dr. Gudjonsson is the Director of the Skin Research Center at the University of Michigan, and his primary research focus is basic immunological and genetic research on chronic inflammatory skin diseases. He has published over 390 peer-reviewed papers in top-tier journals, including Nature Immunology, Nature Genetics, Immunity, Journal of Clinical Investigation (JCI), and Science Translational Medicine. He received the Young Investigator Award from the American Academy of Dermatology (AAD) in 2007, and his work has earned several research awards, including those from the American Skin Association and the Doris Duke Foundation. He was selected as the Society for Investigative Dermatology (SID) Rising Star Lecturer in 2018. He was elected as a member of the American Society for Clinical Investigation (ASCI) in 2020 and the American Association of Physicians (AAP) in 2024 and is a Fellow of the American Association for the Advancement of Science (FAAAS). He has received several NIH R01, UO1, and P awards. He is the Director of the University of Michigan Skin Research Center, an NIH-sponsored P30 Research Core. He is on the Society for Investigative Dermatology Board of Directors, a Scientific Counselor to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and a member of the Board of Directors of the International Psoriasis Foundation (NPF).
Last Updated:
02/19/2026

Areas of Interest

Genetics, Genomics, Immunology of Psoriasis and Other Inflammatory Skin Disorders, Basic and Translational Research, Clinical Trials

IPC Committees / Groups

Board Member, Governance Committee, Research Committee, Symposia Committee

Languages Spoken

English, Icelandic

Involvement with Other Organization(s)

Dr. Gudjonsson serves on the Scientific Advisory and Medical Board of the National Psoriasis Foundation (NPF).
Recent publications

Featured

Blog

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment…

Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…

Read More

Video

Mechanistic Aspects of Paradoxical Reactions and Iatrogenic Switches.

Dr. Johann Gudjonsson discusses the mechanisms of paradoxical reactions and iatrogenic switches, framing them as immune…

Watch Video

PDF

A Report from the 2026 American Academy of Dermatology (AAD) Annual Meeting.

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…

View Report

Blog

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic…

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…

Read More

Blog

2025 IPC Think Tank Congress Report: Psoriasis, Metabolic Health, and GLP-1 Therapies.

The 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…

Read More

Blog

Focus on Psoriasis: Highlights from the 2025 ESDR Annual Meeting.

The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…

Read More

Blog

Focus on Psoriasis: Highlights from the 2025 EADV Congress.

At the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and…

Read More

Page

Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.

Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…

View Report

Blog

Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.

Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…

Read More

PDF

Focus on Psoriasis: Highlights from the 2025 Society for Investigative Dermatology (SID) Annual Meeting.

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

View Report

Blog

Focus on Psoriasis: Highlights from the 2025 Society for Investigative Dermatology (SID) Annual Meeting.

IPC’s 2025 SID Congress Report highlights the most impactful psoriasis sessions, covering novel cell-biology…

Read More

Blog

Highlights from the 2025 American Academy of Dermatology (AAD) Annual Meeting: Psoriasis Comorbidities, New Treatments,…

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

Read More

Video

Lessons from Transcriptomic, Single-cell, and Spatial Analyses in Psoriasis.

Dr. Johann Gudjonsson discusses how single-cell and spatial technologies are revolutionizing our understanding of the…

Watch Video

Blog

Focus on Psoriasis: A Report from the Psoriasis: From Gene to Clinic 10th International Congress.

The Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment…

Read More

Blog

Focus on Psoriasis: A Report from the 2024 IPC Think Tank Symposium – Psoriasis: The Multiple Facets of a Global…

The 2024 IPC Think Tank Congress Report provides a comprehensive summary of key topics, including the epidemiology of…

Read More

Blog

Focus on Psoriasis: A Report from the 53rd Annual European Society for Dermatological Research (ESDR) Meeting.

This report from the 53rd Annual ESDR Meeting in Lisbon covers key presentations on psoriasis, including updates from…

Read More

Page

International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International…

Generalized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…

View Report

Event

Symposium: Advances in Technologies and Analytics in Understanding Psoriasis Pathophysiology.

SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) | DALLAS, TEXAS Wednesday, May 15 9:00 - 12:00 CDT Program chairs:…

May 15, 2024
Learn More or Register

Blog

Focus on Psoriasis: A Report from the 2024 American Academy of Dermatology (AAD) Annual Meeting.

The 2024 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 7 – Tuesday, March 12, 2024,…

Read More

Video

Emerging Mechanistic Data Behind Psoriasis and Cardiometabolic Disease.

Dr. Johann Gudjonsson explores the advancing mechanistic understanding of the correlation between psoriasis and…

Watch Video

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026